Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class I · High risk

Soliris (eculizumab)

Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.

Terminated Particulate / foreign matter Alexion Pharmaceuticals, Inc. NDC 25682-001-01 D-1512-2014
Class II · Moderate risk

HCG 125U/Tab Tablet Tritu

Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.

Terminated Chemical / undeclared Brookfield Prescription Center Inc. dba MD Custom Rx D-1419-2014
Class II · Moderate risk

Diphenhydramine

Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.

Terminated Chemical / undeclared Brookfield Prescription Center Inc. dba MD Custom Rx D-1417-2014
Class II · Moderate risk

Fluvastatin Capsules USP

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.

Terminated Failed specification Teva Pharmaceuticals USA NDC 0093-7442-56 D-1430-2014
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification; out of specification result for particle size distribution during stability testing

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. NDC 0085-1401-01 D-1387-2014
Class III · Low risk

Vasotec (enalapril maleate)

Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.

Terminated Labeling / mix-up Valeant Pharmaceuticals North America LLC NDC 0187-0140-90 D-0019-2015
Class II · Moderate risk

Isoniazid Tablets

Failed Dissolution Specifications: Stability lots cannot support dissolution past the 36 month time point.

Terminated Dissolution failure West-Ward Pharmaceutical Corp. NDC 0143-1261-01 D-1414-2014
Class II · Moderate risk

Mesalamine

Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.

Terminated Particulate / foreign matter Cambrex Charles City Inc D-0447-2017
Class II · Moderate risk

ePHEDrine Sulfate Injection

Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.

Terminated Labeling / mix-up US Compounding Inc D-1548-2014

Recalls by year